GC Genome is moving rapidly with robust R&D capabilities.
Our team are continuously pushing the boundaries of scientific knowledge to enhance the accuracy,
efficiency, and applicability of our clinical genomics technology.
Colorectal Cancer early detection
Lung Cancer early detection
Hepatocellular carcinoma early detection
Pancreatic Cancer early detection
Esophageal Cancer early detection
Ovarian Cancer early detection
non-invasive prenatal testing (NIPT) with machine learning analysis
Prediction of disease-free survival after triple-negative breast cancer treatment
Prediction of PARP inhibitor response
Prediction of PARP inhibitor response using transcriptional mechanism
Discovery Hypertension biomarkers using gut microbes